J. A. Totaro

发表

The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine.

C. C. Porter, J. A. Totaro, A. Burcin, 1965, The Journal of pharmacology and experimental therapeutics.

Identification of functional oxytocin receptors in lactating rat mammary gland in vitro.

D. Pettibone, J. A. Totaro, C. Woyden, 1990, European journal of pharmacology.

COMPARISON OF SOME PHARMACOLOGIC EFFECTS OF CERTAIN 6-SUBSTITUTED DOPAMINE DERIVATIVES WITH RESERPINE, GUANETHIDINE AND METARAMINOL.

C. A. Stone, C. C. Porter, J. A. Totaro, 1963, The Journal of pharmacology and experimental therapeutics.

Inhibition of the serotoninergic uptake system by MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine)

B. Clineschmidt, J. A. Totaro, A. Pflueger, 1978, Pharmacological research communications.

A 5‐HYDROXYTRYPTAMINE‐LIKE MODE OF ANORECTIC ACTION FOR 6‐CHLORO‐2‐[1‐PIPERAZINYL]‐PYRAZINE (MK‐212)

B. Clineschmidt, J. A. Totaro, A. Pflueger, 1978, British journal of pharmacology.

Interaction of taurine and β-alanine with central nervous system neurotransmitter receptors

M. Williams, J. A. Totaro, E. Risley, 1980 .

Comparison of the effects of recently developed alpha 2-adrenergic antagonists with yohimbine and rauwolscine on monoamine synthesis in rat brain.

D. Pettibone, J. A. Totaro, A. B. Pfleuger, 1985, Biochemical pharmacology.

Tetrabenazine-induced depletion of brain monoamines: mechanism by which desmethylimipramine protects cortical norepinephrine.

D. Pettibone, J. A. Totaro, A. Pflueger, 1984, European journal of pharmacology.

Increased concentrations of 3‐methoxy‐4‐hydroxyphenylethyleneglycol and homovanillic acid in rat brain after treatment with BE‐2254 (“HEAT”)

B. Clineschmidt, J. A. Totaro, A. Pflueger, 1975, The Journal of pharmacy and pharmacology.

Displacement of norepinephrine from the rat heart by 14C-metaraminol.

C. A. Stone, M. Torchiana, C. C. Porter, 1967, Biochemical pharmacology.

Inhibition of dopa decarboxylase by the hydrazino analog of α-methyldopa

L. Watson, C. C. Porter, J. A. Totaro, 1962 .

SOME BIOCHEMICAL EFFECTS OF α-METHYL-3,4-DIHYDROXYPHENYLALANINE AND RELATED COMPOUNDS IN MICE

C. C. Porter, J. A. Totaro, C. M. Leiby, 1961 .

Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice.

C. A. Stone, C. C. Porter, J. A. Totaro, 1963, The Journal of pharmacology and experimental therapeutics.

ANTAGONISM OF CERTAIN EFFECTS OF CATECHOLAMINE-DEPLETING AGENTS BY ANTIDEPRESSANT AND RELATED DRUGS.

C. A. Stone, C. C. Porter, J. A. Totaro, 1964, The Journal of pharmacology and experimental therapeutics.

The effect of the optical isomers of alpha-methyl-p-tyrosine upon brain and heart catecholamines in the mouse.

C. C. Porter, J. A. Totaro, A. Burcin, 1966, Biochemical pharmacology.

Restoration of shock‐suppressed behavior by treatment with (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties

M. Williams, B. Clineschmidt, P. R. Bunting, 1982 .

Preparation of some 10-[3-(dimethylamino)-1-propyl]-10H-pyrazino[2,3-b][1,4] benzothiazines as potential neuroleptics.

J. Springer, M. Williams, W. S. Saari, 1983, Journal of medicinal chemistry.

Synthesis, assignment of absolute configuration, and receptor binding studies relevant to the neuroleptic activities of a series of chiral 3-substituted cyproheptadine atropisomers.

K. Rittle, P. Anderson, J. Springer, 1979, Journal of medicinal chemistry.

In vitro pharmacological profile of a novel structural class of oxytocin antagonists.

D. Veber, M. Bock, R. Freidinger, 1991, The Journal of pharmacology and experimental therapeutics.

Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog.

C. A. Stone, J. Blessing, C. C. Porter, 1962, The Journal of pharmacology and experimental therapeutics.

FENFLURAMINE AND BRAIN SEROTONIN

A. G. Zacchei, B. Clineschmidt, J. A. Totaro, 1978, Annals of the New York Academy of Sciences.

Fenfluramine: long-term reduction in brain serotonin (5-hydroxytryptamine).

B. Clineschmidt, J. A. Totaro, A. Pflueger, 1976, European journal of pharmacology.

Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine.

C. A. Stone, M. Williams, B. Clineschmidt, 1979, The Journal of pharmacology and experimental therapeutics.

Heterogeneity of [3H]neurotensin binding: studies with dynorphin, L-156,903 and levocabastine

F. M. Robinson, E. Harris, D. Pettibone, 1988, Brain Research.

Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants.

D. Pettibone, J. A. Totaro, A. Pflueger, 1984, European journal of pharmacology.

Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes.

M. Williams, J. A. Totaro, 1982, European journal of pharmacology.

Fenfluramine-induced enhancement of confinement motor activity: An indirect 5-hydroxytryptamine-like action?

B. Clineschmidt, J. A. Totaro, A. Pflueger, 1975, Neuropharmacology.

High affinity binding of [3H]neurotensin to rat uterus

D. Pettibone, J. A. Totaro, 1987, Peptides.

Inhibition of DOPA decarboxylase by the hydrazino analog of alpha-methylDOPA.

L. Watson, C. C. Porter, J. A. Totaro, 1962, Biochemical pharmacology.

Pharmacokinetics of methyldopa in man.

K. C. Kwan, J. A. Totaro, J. E. Baer, 1976, The Journal of pharmacology and experimental therapeutics.

Bradykinin agonist activity of a novel, potent oxytocin antagonist.

D. Veber, M. Bock, R. Freidinger, 1991, European Journal of Pharmacology.

Interaction of 2‐[β‐(4‐hydroxyphenyl)ethylaminomethyl]tetralone (BE‐2254: ‘HEAT’) with catecholamine receptors in rat brain membranes

M. Williams, B. Clineschmidt, J. A. Totaro, 1978 .

Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivatives.

P. Anderson, W. Randall, M. Williams, 1983, Journal of medicinal chemistry.